We are live on ! Find out more
STRM

Streamline Health Solutions

Delisted

STRM was delisted on the 11th of August, 2025.

41 hedge funds and large institutions have $53.5M invested in Streamline Health Solutions in 2014 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 15 increasing their positions, 6 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 6

25% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 4

3% more capital invested

Capital invested by funds: $52M → $53.5M (+$1.48M)

0% more funds holding

Funds holding: 4141 (0)

Holders
41
Holders Change
Holders Change %
0%
% of All Funds
1.18%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
15
Reduced
6
Closed
4
Calls
Puts
Net Calls
Net Calls Change

STRM Hedge Fund Activity: Q2 2014 in Review

41 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Streamline Health Solutions (STRM) for Q2 2014, worth a combined $53.5M — up 2.8% from $52M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new STRM positions and 4 closed out — a net gain of 1 holder — while 15 added to existing stakes and 6 trimmed.

The largest buyer was Deerfield Management, adding an estimated $2.88M. The largest seller was Sophrosyne Capital, exiting entirely with an estimated $998K sold.

  • 41 institutional investors held Streamline Health Solutions (STRM) as of Q2 2014, unchanged from Q1 2014.
  • Funds reported $53.5M of Streamline Health Solutions stock for Q2 2014, up 2.8% quarter-over-quarter.
  • 5 funds opened new Streamline Health Solutions positions in Q2 2014 and 4 closed out, a net change of +1 holder.
  • The largest Streamline Health Solutions buyer in Q2 2014 was Deerfield Management, an estimated $2.88M added.
  • The largest Streamline Health Solutions seller in Q2 2014 was Sophrosyne Capital, an estimated $998K sold.

Based on aggregated 13F filings for Q2 2014.